Equity Method Investments (Details) € in Millions, $ in Millions |
3 Months Ended | ||||
|---|---|---|---|---|---|
|
Aug. 09, 2024
USD ($)
|
Aug. 09, 2024
EUR (€)
|
Oct. 31, 2025
USD ($)
|
Oct. 31, 2024
USD ($)
|
Aug. 09, 2024
EUR (€)
|
|
| Schedule of Equity Method Investments [Line Items] | |||||
| Cash consideration | $ 0.0 | $ 71.0 | |||
| Medica S.p.A | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Remaining equity interest (percentage) | 51.00% | 51.00% | |||
| Additional ownership acquisition, term (in years) | 3 years | 3 years | |||
| Medica S.p.A | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Equity method investment (percentage) | 49.00% | 49.00% | 49.00% | ||
| Cash consideration | $ 67.9 | € 62.1 | |||
| Capitalized transaction costs | $ 5.8 | € 5.1 | |||
| X | ||||||||||
- Definition Equity Method Investment, Additional Ownership Acquisition, Term No definition available.
|
| X | ||||||||||
- Definition Equity Method Investment, Ownership Percentage, Parent No definition available.
|
| X | ||||||||||
- Definition This element represents the aggregate cost of investments accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|